<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2818">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01477450</url>
  </required_header>
  <id_info>
    <org_study_id>Branson-2010-02</org_study_id>
    <nct_id>NCT01477450</nct_id>
  </id_info>
  <brief_title>Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects</brief_title>
  <official_title>Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Air Force</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the ability of pulsed-dose oxygen from a concentrator to reverse
      altitude-induced hypoxemia compared to compressed gas from a standard oxygen cylinder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be monitored non-invasively with pulse oximetry, end-tidal carbon dioxide,
      tissue oxygenation and ECG. The mean seal level oxygen saturation will be recorded.Subjects
      exposed to an altitude of 14,000 feet will experience moderate hypobaric hypoxia. The mean
      oxygen saturation at this altitude is 83%. Subjects will receive oxygen from both an oxygen
      concentrator or a cylinder of oxygen following exposure to hypobarism. Oxygen from each
      source will be increased in 1 liter per minute increments until the oxygen saturation
      returns to the baseline sea level oxygen saturation.

      The oxygen requirement to return oxygen saturation to baseline values will be recorded. The
      flow from the concentrator and the cylinder will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Return of Oxygen Saturation to Baseline (Sea Level) Values</measure>
    <time_frame>50 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Oxygen will be titrated from either an oxygen concentrator or an oxygen cylinder in liters per minute until the oxygen saturation returns to the sea level value. The flow in liters per minute is the dependent variables. Each participant will experience induced hypoxemia followed by cylinder oxygen delivery; each will also experience induced hypoxemia followed by pulse-dose oxygen from a concentrator.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hypoxemia</condition>
  <condition>Hypobaric Hypoxemia</condition>
  <arm_group>
    <arm_group_label>1 L/min ; 16 mL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 L/min ; 32 mL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 L/min ; 48 mL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulse-dose oxygen</intervention_name>
    <description>Pulsed-dose oxygen delivery from an oxygen concentrator</description>
    <arm_group_label>1 L/min ; 16 mL</arm_group_label>
    <arm_group_label>2 L/min ; 32 mL</arm_group_label>
    <arm_group_label>3 L/min ; 48 mL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cylinder oxygen delivery</intervention_name>
    <description>Oxygen delivery from an oxygen cylinder</description>
    <arm_group_label>1 L/min ; 16 mL</arm_group_label>
    <arm_group_label>2 L/min ; 32 mL</arm_group_label>
    <arm_group_label>3 L/min ; 48 mL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current altitude chamber certification

          -  Age 18 years - 60 years

        Exclusion Criteria:

          -  Current upper respiratory infection

          -  Current symptoms of lower respiratory infection -- productive cough
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Branson, MSc RRT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brooks City Base</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <lastchanged_date>September 24, 2014</lastchanged_date>
  <firstreceived_date>November 18, 2011</firstreceived_date>
  <firstreceived_results_date>January 1, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Rich Branson, M.D.</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Hypobaric hypoxemia</keyword>
  <keyword>Altitude</keyword>
  <keyword>Oxygen</keyword>
  <keyword>oxygen concentrator</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>1 L/Min ; 16 mL</title>
          <description>Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="P2">
          <title>2 L/Min ; 32 mL</title>
          <description>Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="P3">
          <title>3 L/Min ; 48 mL</title>
          <description>Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1 L/Min ; 16 mL</title>
          <description>Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="B2">
          <title>2 L/Min ; 32 mL</title>
          <description>Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="B3">
          <title>3 L/Min ; 48 mL</title>
          <description>Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="10"/>
                <measurement group_id="B4" value="30"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>18-65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="10"/>
                <measurement group_id="B4" value="30"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="2"/>
                <measurement group_id="B4" value="6"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
                <measurement group_id="B2" value="7"/>
                <measurement group_id="B3" value="8"/>
                <measurement group_id="B4" value="24"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="6"/>
                <measurement group_id="B4" value="11"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Not Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="9"/>
                <measurement group_id="B3" value="4"/>
                <measurement group_id="B4" value="19"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Return of Oxygen Saturation to Baseline (Sea Level) Values</title>
        <description>Oxygen will be titrated from either an oxygen concentrator or an oxygen cylinder in liters per minute until the oxygen saturation returns to the sea level value. The flow in liters per minute is the dependent variables. Each participant will experience induced hypoxemia followed by cylinder oxygen delivery; each will also experience induced hypoxemia followed by pulse-dose oxygen from a concentrator.</description>
        <time_frame>50 minutes</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>1 L/Min ; 16 mL</title>
            <description>Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
          </group>
          <group group_id="O2">
            <title>2 L/Min ; 32 mL</title>
            <description>Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
          </group>
          <group group_id="O3">
            <title>3 L/Min ; 48 mL</title>
            <description>Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="10"/>
                  <measurement group_id="O3" value="10"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Return of Oxygen Saturation to Baseline (Sea Level) Values</title>
            <description>Oxygen will be titrated from either an oxygen concentrator or an oxygen cylinder in liters per minute until the oxygen saturation returns to the sea level value. The flow in liters per minute is the dependent variables. Each participant will experience induced hypoxemia followed by cylinder oxygen delivery; each will also experience induced hypoxemia followed by pulse-dose oxygen from a concentrator.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Reversal of hypoxemia after pulse-dose oxygen</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="6"/>
                  <measurement group_id="O2" value="8"/>
                  <measurement group_id="O3" value="10"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Non-reversal of hypoxemia after pulse-dose oxygen</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="2"/>
                  <measurement group_id="O3" value="0"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Reversal of hypoxemia after cylinder O2 delivery</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="9"/>
                  <measurement group_id="O2" value="10"/>
                  <measurement group_id="O3" value="10"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Non-reversal of hypoxemia after cylinder O2 delive</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                  <measurement group_id="O2" value="0"/>
                  <measurement group_id="O3" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.3</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.47</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>1.00</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>1 L/Min ; 16 mL</title>
          <description>Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="E2">
          <title>2 L/Min ; 32 mL</title>
          <description>Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
        <group group_id="E3">
          <title>3 L/Min ; 48 mL</title>
          <description>Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)
Pulse-dose oxygen: Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery: Oxygen delivery from an oxygen cylinder</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard Branson</name_or_title>
      <organization>University of Cincinnati</organization>
      <email>bransord@uc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
